Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran Joanne van Ryn, PhD, Lawrence Baruch, MD, Andreas Clemens, MD The American Journal of Medicine Volume 125, Issue 4, Pages 417-420 (April 2012) DOI: 10.1016/j.amjmed.2011.10.017 Copyright © 2012 Elsevier Inc. Terms and Conditions
Figure 1 Effect of dabigatran on citrated whole blood international normalized ratio (INR) measurement using a laboratory coagulometer and Hemochron Jr. (International Technidyne Corporation, Edison, NJ) point-of-care system. In vitro results from 4 healthy volunteers. Arithmetic mean and SE are shown. The American Journal of Medicine 2012 125, 417-420DOI: (10.1016/j.amjmed.2011.10.017) Copyright © 2012 Elsevier Inc. Terms and Conditions
Figure 2 Effect of dabigatran on activated partial thromboplastin time (aPTT) measurement using a laboratory coagulometer. In vitro results from 4 healthy volunteers. Arithmetic mean and SE are shown. The American Journal of Medicine 2012 125, 417-420DOI: (10.1016/j.amjmed.2011.10.017) Copyright © 2012 Elsevier Inc. Terms and Conditions